ACT Co., Ltd. announced that it expects to receive KRW 5 billion in funding
January 13, 2017
Share
ACT Co., Ltd. (KOSDAQ:A097520) announced a private placement of first unregistered coupon unguaranteed private convertible bond for gross proceeds of KRW 5,000,000,000 on January 13, 2017. The bonds have coupon rate and yield to maturity of 0%. The bonds are 100% convertible in to shares at 10,983 per share. The bonds will mature on on January 17, 2020. The payment date is January 17, 2017. The board of directors have approved the transaction.
Hyupjin Co Ltd, formerly ACT Co Ltd is a Korea-based company engaged in the manufacture and sale of raw materials of cosmetics. The Company provides bioconversion technology products, encapsulated products, natural extracts, synthetic products and others. Its products include Aquatouch L, which is made of glycerin, dimethicone, water and lecithin; Silkytouch L, which is made of water, dimethicone, glycerin, palmitoyl inulin, behenyl alcohol and 1,2 hexanediol; Phytoact Reliefer, which is made of phaseolus radiates seed extract, avena sativa meal extract, ethyhexylglycerin and others, as well as PhytoAct CosyPlex, Actosome InoCeramide E06, Actosome Retinol850, Actosome Retinal Palmitate, Actostem GinElixir and Actosome Deage, among others. It also provides electronic materials.
HYUPJIN CO., LTD. 
